-

2 Day Online Course: Financial Accounting & Reporting - March 15 to 16, 2022 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Financial Accounting & Reporting Update 2022" conference has been added to ResearchAndMarkets.com's offering.

We are seeing an unprecedented level of major accounting changes from US and international standard-setters. This conference will address the latest developments in key areas. Experts from the Big Four and regional firms will lead the discussion.

Learning Objectives:

  • Understand the latest accounting changes in key areas
  • Recognize the timelines and key factors
  • Begin to assess the effects of these standards on your company or clients

Who Should Attend:

  • CFOs (and their staff)
  • Controllers
  • VPs of Finance
  • Accounting Directors and Managers
  • Senior Accountants
  • Revenue Managers and Analysts
  • Internal Auditors
  • Tax Accountants
  • Treasury Staff
  • Internal Control/SOX Managers
  • Public Accountants
  • Educators

Agenda:

Agenda: DAY 1

8:45 - 10:15 SEC Update

  • SEC rulemaking
  • SEC reporting reminders
  • COVID impact
  • Comment letter topics

10:15 - 10:30 Break

10:30 - 11:45 IPOs and SPACs Update

  • SEC Accounting & Reporting Requirements
  • What we are seeing in the market today
  • How valuations have been impacted
  • Accounting considerations

11:45 - 12:15 Lunch

12:15 - 1:30 SOX & Internal Controls Update

  • COVID 19 considerations
  • Sarbanes-Oxley Act Optimization and Modernization
  • Robotic process automation (RPA)
  • Risk assessment
  • ICFR areas of focus: Management review controls (MRCs)
  • Automated Controls (ITACs)
  • Material weaknesses
  • Significant transactions or events
  • Information used in the control (IUC)
  • IT/system implementation
  • System and organization controls (SOC) reports

1:30 - 1:40 Break

1:40 - 2:55 FASB Update

  • Current agenda
  • Recently completed projects

2:55 - 3:05 Break

3:05 - 4:50 Revenue Recognition Update

  • Price concessions
  • Modifying contracts
  • customer options and material rights
  • Performance obligations - software industry considerations
  • Significant financing component
  • Principal - versus - agent considerations
  • Contract costs
  • Onerous performance obligations/contracts

Agenda: DAY 2

8:45 - 10:00 ESG Update

  • Understanding Risks and Opportunities
  • A new way of thinking
  • Report accurately and disclose transparently
  • Create value through ESG principles

10:00 - 10:10 Break

10:10 - 11:20 SEC Enforcement Trends

  • Latest SEC Enforcement Priorities
  • Enforcements Actions and Cases
  • What to look for in 2022

11:20 - 11:30 Break

11:30 - 12:40 Accounting for Debt

  • Latest fallout from COVID-19
  • Accounting for debt modification, exchange, conversion or extinguishment
  • Should the debt be classified as current or noncurrent
  • Have financing arrangements been properly presented and disclosed

12:40 - 12:50 Break

12:50 - 2:20 SEC Comment Letter Update and Legal Issues

  • Market Trends
  • Transaction accounting considerations
  • Non-GAAP Measures, MD&A, Rev Rec, Segment Reporting, Fair Value Measurement, ICFR, Form Compliance, Goodwill, Inventory, Debt

2:20 - 2:30 Break

3:00 - 4:30 Cybersecurity Update

  • Protecting personal data
  • Smart consumer devices expanding faster than controls
  • Personal Health and Medical Devices
  • Ransomware

Speakers

  • Meghan Depp, BDO, National SEC Office
  • Carly Ackerman, Deloitte Consulting, Manager
  • Aleks Zabreyko, Connor Group, Partner
  • Jesse Fillerup, Connor Group, Technical Accounting Director
  • Kristalyn Yancy, Deloitte Consulting, Senior Manager
  • Renton Squires, PwC, Principal
  • Michael Cheng, Frazier & Deeter, National Professional Practice Partner
  • Heather Bradshaw, RSM, Central Region Accounting Methods Leader
  • Karim Anani, Ernst & Young, Partner and EY Americas Financial Accounting Advisory Transaction Leader
  • Kumail Sarwar, Ernst & Young, Senior Manager
  • Justin Sutherland, US Securities and Exchange Commission , Senior Enforcement Accountant
  • Kellyn Shaw, Deloitte, Manager - National Office Accounting & Reporting Services
  • Brad Porter, Deloitte, Manager - National Office Accounting &
  • Tim Kviz, BDO, National Office Managing Partner - SEC Services
  • Muazzam Malik, Protiviti, Managing Director
  • Divyesh Malkan, Protiviti, Senior Manager

For more information about this conference visit https://www.researchandmarkets.com/r/syweb0

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

UAE Automotive Spare Parts E-Commerce Market Size, Share, Growth Drivers, Trends, Opportunities, Competitive Landscape & Forecast 2025-2030 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "UAE Automotive Spare Parts E-Commerce Market Size, Share, Growth Drivers, Trends, Opportunities, Competitive Landscape & Forecast 2025-2030" has been added to ResearchAndMarkets.com's offering. The UAE automotive spare parts e-commerce market, valued at USD 1.2 billion, is experiencing a robust expansion influenced by the surge in online shopping, vehicle ownership, and the need for cost-effective solutions. The convenience provided by e-commerce platforms is r...

Non-Opioid Therapeutics Market Insights, Shares and Growth Outlook 2025-2032: Rising Integration of Non-Opioid Options in Multimodal Pain Management Protocols - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Non-Opioid Therapeutics Market - Global Forecast 2025-2032" has been added to ResearchAndMarkets.com's offering. This market research report focuses on the evolving landscape of the Non-Opioid Therapeutics Market. This sector has grown from USD 40.77 billion in 2024 to USD 43.78 billion in 2025, with projections suggesting a CAGR of 7.68% leading to a valuation of USD 73.72 billion by 2032. Non-opioid therapeutics have become critical in modern pain management, add...

Disulfiram Market Report 2025-2032: Growth Forecast, Segment Shares, FPNV Positioning Matrix and More - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Disulfiram Market - Global Forecast 2025-2032" report has been added to ResearchAndMarkets.com's offering. The Disulfiram Market is advancing in scope and strategic significance as evolving clinical practices, regulatory shifts, and technology continue to reframe substance use disorder management. Senior executives must navigate opportunities and risks shaped by global healthcare transformation, positioning their organizations for competitive relevance. Market Snap...
Back to Newsroom